REVIEW PAPER
Sepsis in HIV-positive patients. What is the scale of the problem and how to approach it?
 
More details
Hide details
 
Submission date: 2016-08-13
 
 
Acceptance date: 2016-11-01
 
 
Publication date: 2017-01-25
 
 
HIV & AIDS Review 2017;16(1):1-4
 
KEYWORDS
TOPICS
ABSTRACT
In the antiretroviral therapy (ART) era, human immunodeficiency virus (HIV)-positive pa-tients are admitted to the hospital in a critical state for various reasons, with a decrease of hospitalizations due to opportunistic infections. About 12-31% of hospitalizations of HIV-infected patients in the intensive care unit (ICU) are due to sepsis. HIV-positive pa-tients with sepsis have a higher mortality rate than HIV-negative patients. Although there are no specific recommendations on how to treat septic HIV-positive patients, it is important to remember which pathogens are the most common causes of infection in this group of patients. More attention should be drawn to nosocomial infections mainly caused by Gram-positive cocci and Gram-negative rods. According to the European AIDS Clinical Society Guidelines (EACS) 2015, ART should be introduced in all HIV-positive patients, regardless of the CD4 cell count. The recommendations do not contain information on treatment of patients with HIV with sepsis. The introduction of ART in HIV-positive patients in a critical state is still debatable due to the drug-drug interactions and route of administration. Though ART in critically ill patients may not affect the hospital survival, it has long-term benefits such as fewer AIDS-related events. The aim of this article was to provide physicians with an overview of recent information on patients with HIV who develop sepsis.
REFERENCES (26)
1.
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 801-810.
 
2.
CDC, Sepsis. CDC’s National Center for Health Statistics (NCHS), Data Reports (2014); http://www.cdc.gov/sepsis/data.... Accessed 15 June 2015.
 
3.
Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310.
 
4.
Jawad I, Lukšić I, Rafnsson SB. Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality. J Glob Health 2012; 2: 010404.
 
5.
Japiassú AM, Amâncio RT, Mesquita EC, et al. Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients. Crit Care 2010; 14: R152.
 
6.
Silva JS, dos Santos S de S. Sepsis in AIDS patients: clinical, etiological and inflammatory characteristics. J Int AIDS Soc 2013; 16: 17344.
 
7.
Casalino E, Wolff M, Ravaud P, et al. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 2004; 18: 1429-1433.
 
8.
Soni N, Pozniak A. Continuing HIV therapy in the ICU. Crit Care 2001; 5: 247-248.
 
9.
Lundgren JD, Gatell JM, Rockstroh JK, et al. European AIDS Clinical Society Guidelines version 8.0 (2015).
 
10.
Greenberg JA, Lennox JL, Martin GS, et al. Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy. J Crit Care 2012; 27: 51-57.
 
11.
Petrosillo N, Pagani L, Ippolito G; Gruppo HIV e Infezioni Ospedaliere. Nosocomial infections in HIV-positive patients: an overview. Infection 2003; 31 Suppl 2: 28-34.
 
12.
Mrus JM, Braun L, Yi M, et al. Impact of HIV/AIDS on care and outcomes of severe sepsis. Crit Care 2005; 9: R623-630.
 
13.
Akgün KM, Tate JP, Pisani M, et al. Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era. Crit Care Med 2013; 41: 1458-1467.
 
14.
Medrano J, Álvaro-Meca A, Boyer A, et al. Mortality of patients infected with HIV in the intensive care unit (2005 through 2010): significant role of chronic hepatitis C and severe sepsis. Crit Care 2014;.
 
15.
18: 475.
 
16.
Dellinger RP, Mitchell ML, Rhodes A, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012, Surviving Sepsis Campaign; http://www.sccm.org/Documents/.... Accessed 15 June 2015.
 
17.
Hoen B, Bonnet F, Delaugerre C, et al. French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults. J Int AIDS Soc 2014; 17: 19034.
 
18.
Lanoix JP, Andrejak C, Schimit JL, et al. Antiretroviral therapy in intensive care unit. Eur J Clin Microbiol Infect Dis 2011; 30:.
 
19.
1085-1093.
 
20.
Masur H. Management of patients with HIV in the Intensive Care Unit. Proc Am Thorac Soc 2006; 3: 96-102.
 
21.
van Lelyveld SF, Wind CM, Mudrikova T. Short- and long-term outcome of HIV-infected patients admitted to the intensive care unit. Eur J Clin Microbiol Infect Dis 2011; 30: 1085-1093.
 
22.
Dickson SJ, Batson S, Copas AJ, et al. Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy. Thorax 2007; 62: 964-968.
 
23.
Chiang HH, Hung CC, Lee CM, et al. Admissions to the intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors. Crit Care 2011; 15: R202.
 
24.
Meybeck A, Lecomte L, Valette M, et al. Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study. AIDS Res Ther 2012; 9: 27.
 
25.
Zolopa AR, Andersen J, Komarow L, et al. Immediate vs deferred ART in the setting of acute AIDS-related opportunistic infection: Final results of a randomized strategy trial, ACTG A5164. In 15th Conference on Retroviruses and Opportunistic Infections, Boston MA, USA, 2008.
 
26.
Orsini J, Ahmad N, Butala A, et al. Etiology and Outcome of Patients with HIV Infection and Respiratory Failure Admitted to the Intensive Care Unit. Interdiscip Perspect Infect Dis 2013; 2013: 732421.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top